 |
Blood
- RENUKARADHYA GJ
, Khan MA, Vieira M, Du W, et al
Type I NKT cells protect (and Type II NKT cells suppress) the host's innate antitumor immune response to a B cell lymphoma.
Blood. 2008;.
PubMed
Related articles
Abstract available
- KHOURI IF
, McLaughlin P, Saliba RM, Hosing C, et al
8-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide and rituximab.
Blood. 2008;.
PubMed
Related articles
Abstract available
- BROWN PJ
, Ashe SL, Leich E, Burek C, et al
Potentially oncogenic B-cell activation-induced smaller isoforms of FOXP1 are highly expressed in the activated B cell-like subtype of DLBCL.
Blood. 2008;111:2816-24.
PubMed
Related articles
Abstract available
Br J Dermatol
- KEMPF W
, Kutzner H, Cozzio A, Sander CA, et al
MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.
Br J Dermatol. 2008;.
PubMed
Related articles
Abstract available
Br J Haematol
- JARES P
, Campo E
Advances in the understanding of mantle cell lymphoma.
Br J Haematol. 2008;.
PubMed
Related articles
Abstract available
- FERRUCCI PF
, Vanazzi A, Grana CM, Cremonesi M, et al
High activity 90Y-ibritumomab tiuxetan (Zevalin) with peripheral blood progenitor cells support in patients with refractory/resistant B-cell non-Hodgkin lymphomas.
Br J Haematol. 2007;139:590-9.
PubMed
Related articles
Abstract available
Cancer Genet Cytogenet
- NAKAMURA Y
, Takahashi N, Kakegawa E, Yoshida K, et al
The GAS5 (growth arrest-specific transcript 5) gene fuses to BCL6 as a result of t(1;3)(q25;q27) in a patient with B-cell lymphoma.
Cancer Genet Cytogenet. 2008;182:144-9.
PubMed
Related articles
Abstract available
J Am Acad Dermatol
- LE EN
, Gerstenblith MR, Gelber AC, Manno RL, et al
The use of blind skin biopsy in the diagnosis of intravascular B-cell lymphoma.
J Am Acad Dermatol. 2008;.
PubMed
Related articles
Abstract available
J Clin Oncol
- SOUSSAIN C
, Hoang-Xuan K, Taillandier L, Fourme E, et al
Intensive Chemotherapy Followed by Hematopoietic Stem-Cell Rescue for Refractory and Recurrent Primary CNS and Intraocular Lymphoma: Societe Francaise de Greffe de Moelle Osseuse-Therapie Cellulaire.
J Clin Oncol. 2008;.
PubMed
Related articles
Abstract available
- PERSKY DO
, Unger JM, Spier CM, Stea B, et al
Phase II Study of Rituximab Plus Three Cycles of CHOP and Involved-Field Radiotherapy for Patients With Limited-Stage Aggressive B-Cell Lymphoma: Southwest Oncology Group Study 0014.
J Clin Oncol. 2008;.
PubMed
Related articles
Abstract available
- BARRY EV
, Vrooman LM, Dahlberg SE, Neuberg DS, et al
Absence of secondary malignant neoplasms in children with high-risk acute lymphoblastic leukemia treated with dexrazoxane.
J Clin Oncol. 2008;26:1106-11.
PubMed
Related articles
Abstract available
J Immunol
- TAWARA T
, Hasegawa K, Sugiura Y, Harada K, et al
Complement activation plays a key role in antibody-induced infusion toxicity in monkeys and rats.
J Immunol. 2008;180:2294-8.
PubMed
Related articles
Abstract available
Lancet Oncol
- GAJRAJ E
, Chung H, Longson C, Stevens A, et al
Rituximab for follicular non-Hodgkin lymphoma.
Lancet Oncol. 2008;9:320-1.
PubMed
Related articles
Leuk Lymphoma
- LIM SH
, Esler WV, Zhang Y, Zhang J, et al
B-cell depletion for 2 years after autologous stem cell transplant for NHL induces prolonged hypogammaglobulinemia beyond the rituximab maintenance period.
Leuk Lymphoma. 2008;49:152-3.
PubMed
Related articles
Oncology
- AWAR O
, Duvic M
Treatment of transformed mycosis fungoides with intermittent low-dose gemcitabine.
Oncology. 2007;73.
PubMed
Related articles
Abstract available